Page last updated: 2024-08-24

triazoles and cardiovascular agents

triazoles has been researched along with cardiovascular agents in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (57.14)	18.2507
2000's	1 (14.29)	29.6817
2010's	1 (14.29)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Damasiewicz, B; Foks, H; Głowka, M; Kaliszan, R; Nasal, A; Okopień, B; Petrusewicz, J; Radwańska, A; Rudnicka, W; Trzeciak, H	1
Czarnocka-Janowicz, A; Damasiewicz, B; Foks, H; Kaliszan, R; Nasal, A; Petrusewicz, J; Radwańska, A	1
el-Sayed, OA; Farghaly, AM; Habib, NS; Khalil, MA	1
Brooks, R; Collis, MG; Keddie, JR; Poucher, SM; Shaw, GR	1
Chawla, PS; Kochar, MS	1
Ao, Z; Bradley, BT; Daniels, E; Douglas, SA; Gatto, GJ; Goodman, KB; Goserud, MT; Harpel, MR; Johns, DG; Kearse, MG; Morales, CR; Zhou, M	1
Balasubramanian, R; Maideen, NMP	1

Reviews

2 review(s) available for triazoles and cardiovascular agents

Article	Year
What's new in clinical pharmacology and therapeutics. WMJ : official publication of the State Medical Society of Wisconsin, 2008, Volume: 107, Issue:2 Topics: Abatacept; Acetanilides; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiparkinson Agents; Antirheumatic Agents; Antiviral Agents; Apomorphine; Benzazepines; Cardiovascular Agents; Fumarates; Hepatitis B; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hypoglycemic Agents; Immunoconjugates; Multiple Sclerosis; Natalizumab; Nucleosides; Papillomavirus Vaccines; Pharmacology, Clinical; Piperazines; Pyrazines; Pyrimidinones; Quinoxalines; Ranolazine; Sitagliptin Phosphate; Smoking Cessation; Telbivudine; Thymidine; Triazoles; Varenicline; Viral Vaccines	2008
HMG-CoA Reductase Inhibitors (Statins) and their Drug Interactions Involving CYP Enzymes, P-glycoprotein and OATP Transporters-An Overview. Current drug metabolism, 2021, Volume: 22, Issue:5 Topics: Anti-Infective Agents; Anticonvulsants; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cardiovascular Agents; Colchicine; Contraceptives, Oral; Cytochrome P-450 CYP3A; Drug Interactions; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Organic Anion Transporters; Phosphodiesterase 5 Inhibitors; Piperazines; Triazoles; Warfarin	2021

Article

Year

What's new in clinical pharmacology and therapeutics.

WMJ : official publication of the State Medical Society of Wisconsin, 2008, Volume: 107, Issue:2

Topics: Abatacept; Acetanilides; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiparkinson Agents; Antirheumatic Agents; Antiviral Agents; Apomorphine; Benzazepines; Cardiovascular Agents; Fumarates; Hepatitis B; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hypoglycemic Agents; Immunoconjugates; Multiple Sclerosis; Natalizumab; Nucleosides; Papillomavirus Vaccines; Pharmacology, Clinical; Piperazines; Pyrazines; Pyrimidinones; Quinoxalines; Ranolazine; Sitagliptin Phosphate; Smoking Cessation; Telbivudine; Thymidine; Triazoles; Varenicline; Viral Vaccines

2008

HMG-CoA Reductase Inhibitors (Statins) and their Drug Interactions Involving CYP Enzymes, P-glycoprotein and OATP Transporters-An Overview.

Current drug metabolism, 2021, Volume: 22, Issue:5

Topics: Anti-Infective Agents; Anticonvulsants; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cardiovascular Agents; Colchicine; Contraceptives, Oral; Cytochrome P-450 CYP3A; Drug Interactions; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Organic Anion Transporters; Phosphodiesterase 5 Inhibitors; Piperazines; Triazoles; Warfarin

2021

Other Studies

5 other study(ies) available for triazoles and cardiovascular agents

Article	Year
Synthesis, structure and biological activity of 1,2,4-triazolo-1,3-thiazine derivatives. Die Pharmazie, 1992, Volume: 47, Issue:10 Topics: Animals; Antitubercular Agents; Cardiotonic Agents; Cardiovascular Agents; Heart Rate; Male; Muscle Contraction; Rats; Rats, Wistar; Structure-Activity Relationship; Thiazines; Triazoles	1992
Synthesis and pharmacological activity of 5-substituted-s-triazole-3-thiols. Die Pharmazie, 1991, Volume: 46, Issue:2 Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular Agents; Epinephrine; Heart; Heart Rate; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Sulfides; Thioglycolates; Triazoles	1991
Synthesis, antimicrobial, inotropic, and chronotropic activities of novel 1,2,4-triazolo[4,3-a]quinolines. Archiv der Pharmazie, 1991, Volume: 324, Issue:4 Topics: Animals; Anti-Bacterial Agents; Anura; Bacteria; Cardiovascular Agents; Heart Rate; In Vitro Techniques; Microbial Sensitivity Tests; Myocardial Contraction; Quinolines; Triazoles	1991
In vivo characterisation of ZM 241385, a selective adenosine A2A receptor antagonist. European journal of pharmacology, 1996, Apr-22, Volume: 301, Issue:1-3 Topics: Adenosine; Animals; Cardiovascular Agents; Decerebrate State; Dogs; Female; Heart Rate; Hindlimb; In Vitro Techniques; Myocardial Contraction; Purinergic P1 Receptor Antagonists; Rats; Rats, Inbred SHR; Regional Blood Flow; Triazines; Triazoles; Vasodilation	1996
NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation. Journal of enzyme inhibition and medicinal chemistry, 2013, Volume: 28, Issue:1 Topics: Base Sequence; Benzoxazoles; Cardiovascular Agents; Cells, Cultured; Enzyme Inhibitors; Humans; Membrane Glycoproteins; Molecular Sequence Data; NADPH Oxidase 2; NADPH Oxidases; Neutrophils; Perhexiline; Protein Kinase C; Protein Kinase C beta; Reactive Oxygen Species; Suramin; Triazoles	2013